Azerbaijan remains a high MDR-TB burden country. There is a need to implement countrywide control and innovative measures to accelerate early diagnosis of drug resistance in individual patients, improve treatment adherence and strengthen routine surveillance of drug resistance.
No takes yet. Share an insight, caveat, or question.
Alikhanova et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: